RT Journal Article
SR Electronic
T1 LAMP-BEAC: Detection of SARS-CoV-2 RNA Using RT-LAMP and Molecular Beacons
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.13.20173757
DO 10.1101/2020.08.13.20173757
A1 Sherrill-Mix, Scott
A1 Hwang, Young
A1 Roche, Aoife M.
A1 Weiss, Susan R.
A1 Li, Yize
A1 Graham-Wooten, Jevon
A1 Taylor, Louis J.
A1 Collman, Ronald G.
A1 Van Duyne, Gregory D.
A1 Bushman, Frederic D.
YR 2020
UL http://medrxiv.org/content/early/2020/08/19/2020.08.13.20173757.abstract
AB SARS-CoV-2 has caused a global pandemic, resulting in the need for rapid assays to allow diagnosis and prevention of transmission. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) provides a gold standard assay for SARS-CoV-2 RNA, but tests are expensive and supply chains are potentially fragile, motivating interest in additional assay methods. Reverse transcription and Loop Mediated Isothermal Amplification (RT-LAMP) provides an alternative that uses alternative and often cheaper reagents without the need for thermocyclers. The presence of SARS-CoV-2 RNA is typically detected using dyes to report bulk amplification of DNA; however a common artifact is nonspecific DNA amplification, complicating detection. Here we describe the design and testing of molecular beacons, which allow sequence-specific detection of SARS-CoV-2 genomes with improved discrimination in simple reaction mixtures. We also show how beacons with different fluorescent labels can allow convenient multiplex detection of several amplicons in “single pot” reactions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Center for Research on Coronaviruses and Other Emerging Pathogens.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Pennsylvania Institutional Review Board (IRB)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data supporting the findings of this study are available within the article.